Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mohawk Industries, Inc. (NYSE:MHK): Are Hedge Funds Right About This Stock?

Mohawk Industries, Inc. (NYSE:MHK) has seen an increase in enthusiasm from smart money lately.

In today’s marketplace, there are dozens of methods investors can use to track stocks. Some of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top investment managers can beat the broader indices by a healthy margin (see just how much).

Mohawk Industries, Inc.

Just as key, optimistic insider trading sentiment is another way to parse down the financial markets. Obviously, there are many incentives for an upper level exec to cut shares of his or her company, but just one, very clear reason why they would behave bullishly. Several empirical studies have demonstrated the impressive potential of this method if “monkeys” know where to look (learn more here).

Now, we’re going to take a peek at the latest action regarding Mohawk Industries, Inc. (NYSE:MHK).

How have hedgies been trading Mohawk Industries, Inc. (NYSE:MHK)?

At year’s end, a total of 33 of the hedge funds we track were long in this stock, a change of 27% from one quarter earlier. With hedgies’ capital changing hands, there exists a few noteworthy hedge fund managers who were upping their stakes substantially.

When looking at the hedgies we track, Citadel Investment Group, managed by Ken Griffin, holds the biggest position in Mohawk Industries, Inc. (NYSE:MHK). Citadel Investment Group has a $224 million billion position in the stock, comprising 0.3% of its 13F portfolio. Sitting at the No. 2 spot is Patrick Degorce of Theleme Partners, with a $72 million position; 5.5% of its 13F portfolio is allocated to the stock. Other peers with similar optimism include John W. Rogers’s Ariel Investments, Chuck Royce’s Royce & Associates and Ken Heebner’s Capital Growth Management.

Now, specific money managers have been driving this bullishness. Theleme Partners, managed by Patrick Degorce, created the most outsized position in Mohawk Industries, Inc. (NYSE:MHK). Theleme Partners had 72 million invested in the company at the end of the quarter. Ken Heebner’s Capital Growth Management also made a $47 million investment in the stock during the quarter. The following funds were also among the new MHK investors: John Lykouretzos’s Hoplite Capital Management, Donald Chiboucis’s Columbus Circle Investors, and Robert Joseph Caruso’s Select Equity Group.

How are insiders trading Mohawk Industries, Inc. (NYSE:MHK)?

Insider trading activity, especially when it’s bullish, is particularly usable when the company in question has seen transactions within the past 180 days. Over the last half-year time frame, Mohawk Industries, Inc. (NYSE:MHK) has experienced zero unique insiders purchasing, and 11 insider sales (see the details of insider trades here).

With the results shown by our studies, retail investors must always keep an eye on hedge fund and insider trading sentiment, and Mohawk Industries, Inc. (NYSE:MHK) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!